Effettuare il login Iscriviti gratis

Alimera Sciences Ret. sull'asset

Cos'è Ret. sull'asset di Alimera Sciences?

Ret. sull'asset di Alimera Sciences Inc. è -9.63%

Qual è la definizione di Ret. sull'asset?



Il rendimento delle attività indica quanto redditizie le attività di un'azienda stanno generando entrate. Viene calcolato dividendo il reddito netto per il patrimonio medio totale.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. sull'asset di aziende nel Health Care settore su NASDAQ rispetto a Alimera Sciences

Cosa fa Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Aziende con ret. sull'asset simili a Alimera Sciences